Literature DB >> 30355030

Mechanisms of Connexin-Related Lymphedema.

Jorge A Castorena-Gonzalez1, Scott D Zawieja1, Min Li1, R Sathish Srinivasan2, Alexander M Simon3, Cor de Wit4, Roger de la Torre5, Luis A Martinez-Lemus1, Grant W Hennig6, Michael J Davis1.   

Abstract

RATIONALE: Mutations in GJC2 and GJA1, encoding Cxs (connexins) 47 and 43, respectively, are linked to lymphedema, but the underlying mechanisms are unknown. Because efficient lymph transport relies on the coordinated contractions of lymphatic muscle cells (LMCs) and their electrical coupling through Cxs, Cx-related lymphedema is proposed to result from dyssynchronous contractions of lymphatic vessels.
OBJECTIVE: To determine which Cx isoforms in LMCs and lymphatic endothelial cells are required for the entrainment of lymphatic contraction waves and efficient lymph transport. METHODS AND
RESULTS: We developed novel methods to quantify the spatiotemporal entrainment of lymphatic contraction waves and used optogenetic techniques to analyze calcium signaling within and between the LMC and the lymphatic endothelial cell layers. Genetic deletion of the major lymphatic endothelial cell Cxs (Cx43, Cx47, or Cx37) revealed that none were necessary for the synchronization of the global calcium events that triggered propagating contraction waves. We identified Cx45 in human and mouse LMCs as the critical Cx mediating the conduction of pacemaking signals and entrained contractions. Smooth muscle-specific Cx45 deficiency resulted in 10- to 18-fold reduction in conduction speed, partial-to-severe loss of contractile coordination, and impaired lymph pump function ex vivo and in vivo. Cx45 deficiency resulted in profound inhibition of lymph transport in vivo, but only under an imposed gravitational load.
CONCLUSIONS: Our results (1) identify Cx45 as the Cx isoform mediating the entrainment of the contraction waves in LMCs; (2) show that major endothelial Cxs are dispensable for the entrainment of contractions; (3) reveal a lack of coupling between lymphatic endothelial cells and LMCs, in contrast to arterioles; (4) point to lymphatic valve defects, rather than contraction dyssynchrony, as the mechanism underlying GJC2- or GJA1-related lymphedema; and (5) show that a gravitational load exacerbates lymphatic contractile defects in the intact mouse hindlimb, which is likely critical for the development of lymphedema in the adult mouse.

Entities:  

Keywords:  calcium signaling; connexins; lymph; lymphatic system; lymphedema; vascular disease

Mesh:

Substances:

Year:  2018        PMID: 30355030      PMCID: PMC6771293          DOI: 10.1161/CIRCRESAHA.117.312576

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  132 in total

1.  Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion.

Authors:  Cor de Wit; Frederik Roos; Steffen-Sebastian Bolz; Ulrich Pohl
Journal:  Physiol Genomics       Date:  2003-04-16       Impact factor: 3.107

Review 2.  Connexins: key mediators of endocrine function.

Authors:  Domenico Bosco; Jacques-Antoine Haefliger; Paolo Meda
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

3.  Lower-extremity lymphedema and elevated body-mass index.

Authors:  Arin K Greene; Frederick D Grant; Sumner A Slavin
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

4.  Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man.

Authors:  Patricia E Burrows; Manuel L Gonzalez-Garay; John C Rasmussen; Melissa B Aldrich; Renie Guilliod; Erik A Maus; Caroline E Fife; Sunkuk Kwon; Philip E Lapinski; Philip D King; Eva M Sevick-Muraca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.

Authors:  A Irrthum; M J Karkkainen; K Devriendt; K Alitalo; M Vikkula
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

6.  Measurement of cytosolic Ca2+ in isolated contractile lymphatics.

Authors:  Flavia M Souza-Smith; Kristine M Kurtz; Jerome W Breslin
Journal:  J Vis Exp       Date:  2011-12-08       Impact factor: 1.355

7.  Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.

Authors:  A Ghalamkarpour; S Morlot; A Raas-Rothschild; A Utkus; J B Mulliken; L M Boon; M Vikkula
Journal:  Clin Genet       Date:  2006-10       Impact factor: 4.438

8.  Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery.

Authors:  Jennifer S Fang; Stoyan N Angelov; Alexander M Simon; Janis M Burt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

9.  Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.

Authors:  David N Finegold; Catherine J Baty; Kelly Z Knickelbein; Shelley Perschke; Sarah E Noon; Diana Campbell; Jenny M Karlsson; Diana Huang; Mark A Kimak; Elizabeth C Lawrence; Eleanor Feingold; Stephen D Meriney; Adam M Brufsky; Robert E Ferrell
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

10.  TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.

Authors:  Nicholas W Clavin; Tomer Avraham; John Fernandez; Sanjay V Daluvoy; Marc A Soares; Arif Chaudhry; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

View more
  22 in total

1.  Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.

Authors:  Rafael S Czepielewski; Emma C Erlich; Emily J Onufer; Shannon Young; Brian T Saunders; Yong-Hyun Han; Mary Wohltmann; Peter L Wang; Ki-Wook Kim; Shashi Kumar; Chyi-Song Hsieh; Joshua P Scallan; Ying Yang; Bernd H Zinselmeyer; Michael J Davis; Gwendalyn J Randolph
Journal:  Immunity       Date:  2021-11-16       Impact factor: 31.745

Review 2.  KATP channels in lymphatic function.

Authors:  Michael J Davis; Hae Jin Kim; Colin G Nichols
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

3.  Intracellular calcium dynamics of lymphatic endothelial and muscle cells co-cultured in a Lymphangion-Chip under pulsatile flow.

Authors:  Amirali Selahi; Sanjukta Chakraborty; Mariappan Muthuchamy; David C Zawieja; Abhishek Jain
Journal:  Analyst       Date:  2022-06-27       Impact factor: 5.227

4.  Simplified method to quantify valve back-leak uncovers severe mesenteric lymphatic valve dysfunction in mice deficient in connexins 43 and 37.

Authors:  Jorge A Castorena-Gonzalez; R Sathish Srinivasan; Philip D King; Alexander M Simon; Michael J Davis
Journal:  J Physiol       Date:  2020-05-10       Impact factor: 5.182

5.  Kir6.1-dependent KATP channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain-of-function.

Authors:  Michael J Davis; Hae Jin Kim; Scott D Zawieja; Jorge A Castorena-Gonzalez; Peichun Gui; Min Li; Brian T Saunders; Bernd H Zinselmeyer; Gwendalyn J Randolph; Maria S Remedi; Colin G Nichols
Journal:  J Physiol       Date:  2020-05-30       Impact factor: 5.182

Review 6.  Biochemical and mechanical signals in the lymphatic vasculature.

Authors:  Xin Geng; Yen-Chun Ho; R Sathish Srinivasan
Journal:  Cell Mol Life Sci       Date:  2021-07-08       Impact factor: 9.261

Review 7.  Cellular mechanisms of connexin-based inherited diseases.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Trends Cell Biol       Date:  2021-08-21       Impact factor: 20.808

Review 8.  Vascular endothelial cell specification in health and disease.

Authors:  Corina Marziano; Gael Genet; Karen K Hirschi
Journal:  Angiogenesis       Date:  2021-04-12       Impact factor: 9.596

9.  Fluid pumping of peristaltic vessel fitted with elastic valves.

Authors:  Ki Tae Wolf; J Brandon Dixon; Alexander Alexeev
Journal:  J Fluid Mech       Date:  2021-05-11       Impact factor: 4.245

Review 10.  Lymphatic Connexins and Pannexins in Health and Disease.

Authors:  Avigail Ehrlich; Filippo Molica; Aurélie Hautefort; Brenda R Kwak
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.